Condition
Somatostatin Receptor Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Somatostatin Receptor Positive clinical trials that are recruiting, at sites in 3 countries (most in United States (3), France (1), Spain (1)). By phase: Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Somatostatin Receptor Positive clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Targeted alpha therapy [212Pb]VMT-Alpha-NET for SSTR-positive metastatic or inoperable GI neuroendocrine, pheochromocytoma/paraganglioma, small cell lung, kidney, and head & neck cancers | Phase 1 | Bethesda, Maryland | Recruiting | Jun 28, 2024 |
| Lutetium Lu 177 Edotreotide dose-finding for children with SSTR-positive tumors | Phase 1 | Palo Alto, California and 8 other locations | Recruiting | Jun 4, 2024 |
| Targeted treatment for advanced gastrointestinal neuroendocrine tumors and pheochromocytoma | Phase 1/2 | Bethesda, Maryland | Recruiting | May 24, 2024 |
All recruiting trials (3)
-
Targeted alpha therapy [212Pb]VMT-Alpha-NET for SSTR-positive metastatic or inoperable GI neuroendocrine, pheochromocytoma/paraganglioma, small cell lung, kidney, and head & neck cancers
This trial will try an experimental targeted alpha-particle drug called [212Pb]VMT-Alpha-NET in adults whose metastatic or inoperable tumors show somatostatin receptor (SSTR) expression.
-
Lutetium Lu 177 Edotreotide dose-finding for children with SSTR-positive tumors
This test gives Lutetium Lu 177 Edotreotide to children ages 2 to under 18 with somatostatin receptor–positive tumors to find a safe pediatric dose and see how the drug behaves in the body.
-
Targeted treatment for advanced gastrointestinal neuroendocrine tumors and pheochromocytoma
This study is testing a new drug to see if it can help people with advanced gastrointestinal neuroendocrine tumors and pheochromocytoma who have already tried other treatments.
Related topics
Quick answers
How many Somatostatin Receptor Positive clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.